Figure 2From: Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatmentChange over time in HbA1c, following treatment with linagliptin 5 mg or placebo for 24 weeks (reproduced from Taskinem et al.) [[21]].Back to article page